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ABOUT THE COVER
Disruption of DNA repair capacity is associated with cancer susceptibility, but it
remains unclear if the inherent tumor phenotypes of DNA repair deficiency
syndromes can be regulated by manipulating DNA repair pathways. BLM is a
structure-specific helicase which functions in many aspects of DNA homeostasis.
Increasing BLM dosage in vivo in the pink-eyed unstable (pun) mouse model lowers
endogenous levels of homologous recombination (HR). Transgenic expression of
BLM reduces pigmented eye-spots that spontaneously develop in mouse retinal
pigment epithelial (RPE) cells. In punmice, eye-spots arise because of a characteristic
intra-chromosomal, HR-dependent deletion within the mouse p gene which
restores melanin production in the otherwise transparent cells of the RPE. Thus,
absolute numbers of RPE eye-spots represent an in vivo read-out of HR levels. The
cover illustration depicts a clone of (five) pigmented cells in a RPE whole mount,
originating from a single reversion event. Brown melanosomes are restricted to the
cytoplasm, defining cell nuclei as clear regions. For more information on the effects
of transgenic BLM expression on the intestinal tumor burden and pathology of
ApcMin/þ mouse models of familial adenomatous polyposis coli, see the article by
McIlhatton et al. (beginning on page 650).
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